|
|
|
|
|
|
|
|
|||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
Journal of Cell Science, Vol 110, Issue 9 1091-1098, Copyright © 1997 by Company of Biologists
JOURNAL ARTICLES |
E Planus, G Barlovatz-Meimon, RA Rogers, S Bonavaud, DE Ingber and N Wang
Department of Environmental Health, Harvard School of Public Health, Boston, MA 02115, USA.
Urokinase plasminogen activator and its receptor are both found at the surface of the cell membrane in many cell types. The plasminogen activator inhibitor type-1 (PAI-1) is often associated with the extracellular matrix. The spatial localization of these three molecules could account for their involvement in cell adhesion and/or migration. We have shown previously that the urokinase receptor mediates mechanical force transmission across the cell surface to the cytoskeleton. Here we investigated whether immobilized plasminogen activator inhibitor type 1 (PAI-1) could regulate cell spreading and cytoskeleton reorganization. Serum deprived human myogenic cells were plated in serum free medium onto bacteriologic dishes precoated with different extracellular matrix ligands (fibronectin, vitronectin, or type 1 collagen) or PAI-1 at increasing concentrations. The number of adherent cells and their projected area were quantitated after 3 hours of plating. PAI-1 promoted cell adhesion and spreading in a dose dependent manner. Addition of antibodies to PAI-1 inhibited the adhesion on PAI-1 coated dishes in a dose dependent way. The PAI-1 mediated cell adhesion required the presence of urokinase at the cell surface. Removal of the glycosylphosphatidylinositol (GPI)-linked proteins abolished cell adhesion on PAI-1 dish, suggesting its dependence on the presence of the urokinase receptor, a GPI-linked receptor. Furthermore, addition of antibodies against alpha v beta3 integrin completely inhibited cell adhesion on PAI-1, suggesting that alpha v beta3 might be the transmembrane molecule that physically connects the complex of PAI-1, urokinase, and urokinase receptor to the cytoskeleton. Visualization of spread cells stained for filamentous actin with confocal microscopy showed a dose-dependent increase of filopodia on PAI-1 coated dishes and cytoskeletal reorganization, suggesting a migratory profile. These data indicate that PAI-1 plays a direct role in dynamic cell adhesion particularly at the leading edge, where increased levels of urokinase plasminogen activator (uPA) and its receptor (uPAR) are localized in migrating cells. Immobilized PAI-1 could therefore serve to bridge the cell surface with the extracellular matrix via the formation of a multimolecular complex that includes alpha v beta3 integrins in myogenic cells.
This article has been cited by other articles:
|
|
 |
|
  E. Arciniegas, M. G. Frid, I. S. Douglas, and K. R. Stenmark Perspectives on endothelial-to-mesenchymal transition: potential contribution to vascular remodeling in chronic pulmonary hypertension Am J Physiol Lung Cell Mol Physiol, July 1, 2007; 293(1): L1 - L8. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Maquerlot, S. Galiacy, M. Malo, C. Guignabert, D. A. Lawrence, M.-P. d'Ortho, and G. Barlovatz-Meimon Dual Role for Plasminogen Activator Inhibitor Type 1 as Soluble and as Matricellular Regulator of Epithelial Alveolar Cell Wound Healing Am. J. Pathol., November 1, 2006; 169(5): 1624 - 1632. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-H. Kwak, S. Mitra, K. Bdeir, D. Strassheim, J. S. Park, J. Y. Kim, S. Idell, D. Cines, and E. Abraham The kringle domain of urokinase-type plasminogen activator potentiates LPS-induced neutrophil activation through interaction with {alpha}V{beta}3 integrins J. Leukoc. Biol., October 1, 2005; 78(4): 937 - 945. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Puig-de-Morales, E. Millet, B. Fabry, D. Navajas, N. Wang, J. P. Butler, and J. J. Fredberg Cytoskeletal mechanics in adherent human airway smooth muscle cells: probe specificity and scaling of protein-protein dynamics Am J Physiol Cell Physiol, September 1, 2004; 287(3): C643 - C654. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. L. Wahl, T. L. Moser, and S. V. Pizzo Angiostatin and Anti-angiogenic Therapy in Human Disease Recent Prog. Horm. Res., January 1, 2004; 59(1): 73 - 104. [Abstract] [Full Text]
|
|
|
|
 |
|
 A. E. Barani, A.-C. Durieux, O. Sabido, and D. Freyssenet Age-related changes in the mitotic and metabolic characteristics of muscle-derived cells J Appl Physiol, November 1, 2003; 95(5): 2089 - 2098. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Hirashima, H. Kobayashi, M. Suzuki, Y. Tanaka, N. Kanayama, and T. Terao Transforming Growth Factor-{beta}1 Produced by Ovarian Cancer Cell Line HRA Stimulates Attachment and Invasion through an Up-regulation of Plasminogen Activator Inhibitor Type-1 in Human Peritoneal Mesothelial Cells J. Biol. Chem., July 11, 2003; 278(29): 26793 - 26802. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Tanaka, H. Koyama, T. Ichii, A. Shioi, M. Hosoi, E. W. Raines, and Y. Nishizawa Fibrillar Collagen Regulation of Plasminogen Activator Inhibitor-1 Is Involved in Altered Smooth Muscle Cell Migration Arterioscler. Thromb. Vasc. Biol., October 1, 2002; 22(10): 1573 - 1578. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Chazaud, R. Ricoux, C. Christov, A. Plonquet, R. K. Gherardi, and G. Barlovatz-Meimon Promigratory Effect of Plasminogen Activator Inhibitor-1 on Invasive Breast Cancer Cell Populations Am. J. Pathol., January 1, 2002; 160(1): 237 - 246. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. A. Wickstrom, T. Veikkola, M. Rehn, T. Pihlajaniemi, K. Alitalo, and J. Keski-Oja Endostatin-induced Modulation of Plasminogen Activation with Concomitant Loss of Focal Adhesions and Actin Stress Fibers in Cultured Human Endothelial Cells Cancer Res., September 1, 2001; 61(17): 6511 - 6516. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A J Wilson and P R Gibson Role of urokinase and its receptor in basal and stimulated colonic epithelial cell migration in vitro Gut, July 1, 2000; 47(1): 105 - 111. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Ikari, K. Fujikawa, K. O. Yee, and S. M. Schwartz alpha 1-Proteinase Inhibitor, alpha 1-Antichymotrypsin, or alpha 2-Macroglobulin Is Required for Vascular Smooth Muscle Cell Spreading in Three-dimensional Fibrin Gel J. Biol. Chem., April 21, 2000; 275(17): 12799 - 12805. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Montero and Y. Nagamine Regulation by p38 Mitogen-activated Protein Kinase of Adenylate- and Uridylate-Rich Element-mediated Urokinase-Type Plasminogen Activator (uPA) Messenger RNA Stability and uPA-dependent in Vitro Cell Invasion Cancer Res., October 1, 1999; 59(20): 5286 - 5293. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Robert, I. Bolon, S. Gazzeri, S. Veyrenc, C. Brambilla, and E. Brambilla Expression of Plasminogen Activator Inhibitors 1 and 2 in Lung Cancer and Their Role in Tumor Progression Clin. Cancer Res., August 1, 1999; 5(8): 2094 - 2102. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Liu, J. Yao, I. de Belle, R.-P. Huang, E. Adamson, and D. Mercola The Transcription Factor EGR-1 Suppresses Transformation of Human Fibrosarcoma HT1080 Cells by Coordinated Induction of Transforming Growth Factor-beta 1, Fibronectin, and Plasminogen Activator Inhibitor-1 J. Biol. Chem., February 12, 1999; 274(7): 4400 - 4411. [Abstract] [Full Text] [PDF]
|
|
